Literature DB >> 14654713

Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling.

Vesna Evtimova1, Robert Zeillinger, Ulrich H Weidle.   

Abstract

We derived the transcriptional profiles of four invasive and four noninvasive mammary carcinoma cell lines by Affymetrix GeneChip((R)) Technology with the profile of human mammary epithelial cells as a reference. We focused on the identification of genes which are upregulated in the invasive cell lines based on the following threshold levels: -fold change of 2 or higher in at least three or more cell lines. According to the scoring criteria as described above, we identified 18 transmembrane receptors, 18 secreted proteins and 5 kinases. Several of the genes described have already been put into context with respect to invasion of mammary carcinoma. We therefore focused on deregulated genes for which such an association has not been described before: transmembrane receptor tyrosine kinase DDR2, transmembrane receptors PMP22 and EMP3 and cell adhesion molecule N-cadherin. Making use of real-time PCR, consistently increased steady-state levels of mRNAs for these genes were found in an extended panel of invasive and noninvasive mammary cancer cell lines. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654713     DOI: 10.1159/000074429

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  15 in total

Review 1.  Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Authors:  Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai A Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

Review 2.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

Review 3.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

4.  Biomarkers for EMT and MET in breast cancer: An update.

Authors:  Fei Liu; Li-Na Gu; Bao-En Shan; Cui-Zhi Geng; Mei-Xiang Sang
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

Review 5.  Molecular profiling of hepatocellular carcinomas by cDNA microarray.

Authors:  Lian-Hai Zhang; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

6.  Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.

Authors:  Jochen F Peter; Angela M Otto; Bernhard Wolf
Journal:  J Biomol Tech       Date:  2007-12

7.  TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype.

Authors:  Monzur Rahman; Sean R Davis; Janet G Pumphrey; Jing Bao; Marion M Nau; Paul S Meltzer; Stanley Lipkowitz
Journal:  Breast Cancer Res Treat       Date:  2008-02-12       Impact factor: 4.872

8.  Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.

Authors:  Dan Tong; Georg Heinze; Dietmar Pils; Andrea Wolf; Christian F Singer; Nicole Concin; Gerda Hofstetter; Ingrid Schiebel; Margaretha Rudas; Robert Zeillinger
Journal:  BMC Cancer       Date:  2010-12-15       Impact factor: 4.430

9.  Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts.

Authors:  Lucia Micutkova; Thomas Diener; Chen Li; Adelina Rogowska-Wrzesinska; Christoph Mueck; Eveline Huetter; Birgit Weinberger; Beatrix Grubeck-Loebenstein; Peter Roepstorff; Rong Zeng; Pidder Jansen-Duerr
Journal:  Mech Ageing Dev       Date:  2011-07-24       Impact factor: 5.432

10.  Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.

Authors:  Joeri Both; Thijs Wu; Johannes Bras; Gerard R Schaap; Frank Baas; Theo J M Hulsebos
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.